rewirebio.iobenchmarks
Dataset

Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)

Public cfDNA targeted-panel sequencing of 48 breast, 49 lung and 54 prostate cancers and 47 non-cancer donors (508-gene GRAIL panel, about 2.0 Mb, >60,000x).

Evaluation results

52 evaluations · 260 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.954 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.896 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.958 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.983 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Prostate'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.953 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Breast'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.893 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Lung'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.957 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Mean AUROC'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Normal'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.981 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Prostate'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.933 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Breast'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.868 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Lung'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.941 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Mean AUROC'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Normal'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.963 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Prostate'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.947 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Breast'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.921 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Lung'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.962 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Mean AUROC'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Normal'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.982 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Prostate'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.936 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Breast'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.914 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Lung'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.952 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Mean AUROC'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.993 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Normal'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.963 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Prostate'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

20 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Assay
Hybrid-capture targeted sequencing of cfDNA, 508 genes
Context-only references
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications 16, published online 2025-10-14; Europe PMC full-text JATS XML of PMC12521513
Retrieved: 2026-10-11T21:40:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 48e63b9225dd6b4b8f67e25c58a026e9a7183eb790c5900e752a6d2f70ead835

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
Hybrid-capture targeted sequencing of cfDNA, 508 genes
Context-only references
Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2)

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41467_2025_64153_MOESM1_ESM.pdf, publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 3fe7690ed5d7227d4b0c51c5d70d69ca947a26da7d51928c45a209b88fe79b6e

Hash scope: pdftotext -layout (poppler 26.08.0) text layer, parsed by extract/extract_helzer2025.py

Inspected artifact

Negatives
47
Context-only references
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications 16, published online 2025-10-14; Europe PMC full-text JATS XML of PMC12521513
Retrieved: 2026-10-11T21:40:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 48e63b9225dd6b4b8f67e25c58a026e9a7183eb790c5900e752a6d2f70ead835

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Negatives
47
Context-only references
Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2)

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41467_2025_64153_MOESM1_ESM.pdf, publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 3fe7690ed5d7227d4b0c51c5d70d69ca947a26da7d51928c45a209b88fe79b6e

Hash scope: pdftotext -layout (poppler 26.08.0) text layer, parsed by extract/extract_helzer2025.py

Inspected artifact

Population
48 breast, 49 lung and 54 prostate cancers (metastatic) and 47 healthy donors; cancer subtypes not available
Context-only references
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications 16, published online 2025-10-14; Europe PMC full-text JATS XML of PMC12521513
Retrieved: 2026-10-11T21:40:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 48e63b9225dd6b4b8f67e25c58a026e9a7183eb790c5900e752a6d2f70ead835

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
48 breast, 49 lung and 54 prostate cancers (metastatic) and 47 healthy donors; cancer subtypes not available
Context-only references
Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2)

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41467_2025_64153_MOESM1_ESM.pdf, publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 3fe7690ed5d7227d4b0c51c5d70d69ca947a26da7d51928c45a209b88fe79b6e

Hash scope: pdftotext -layout (poppler 26.08.0) text layer, parsed by extract/extract_helzer2025.py

Inspected artifact

Positives
151
Context-only references
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications 16, published online 2025-10-14; Europe PMC full-text JATS XML of PMC12521513
Retrieved: 2026-10-11T21:40:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 48e63b9225dd6b4b8f67e25c58a026e9a7183eb790c5900e752a6d2f70ead835

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Positives
151
Context-only references
Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2)

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41467_2025_64153_MOESM1_ESM.pdf, publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 3fe7690ed5d7227d4b0c51c5d70d69ca947a26da7d51928c45a209b88fe79b6e

Hash scope: pdftotext -layout (poppler 26.08.0) text layer, parsed by extract/extract_helzer2025.py

Inspected artifact

Scope note
Public data generated by GRAIL for Razavi et al. 2019; the Helzer et al. authors did not generate it.
Context-only references
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications 16, published online 2025-10-14; Europe PMC full-text JATS XML of PMC12521513
Retrieved: 2026-10-11T21:40:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 48e63b9225dd6b4b8f67e25c58a026e9a7183eb790c5900e752a6d2f70ead835

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Public data generated by GRAIL for Razavi et al. 2019; the Helzer et al. authors did not generate it.
Context-only references
Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2)

Original source ↗

Results P7; Figure S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41467_2025_64153_MOESM1_ESM.pdf, publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 3fe7690ed5d7227d4b0c51c5d70d69ca947a26da7d51928c45a209b88fe79b6e

Hash scope: pdftotext -layout (poppler 26.08.0) text layer, parsed by extract/extract_helzer2025.py

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-helzer2025-data-grail-razavi2019.

Source locator: Results P7; Figure S1

Related records

Suggest a correction